Status:
UNKNOWN
Study of Eplets Matching in Kidney Transplantation
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Conditions:
Kidney Transplantation
Eligibility:
All Genders
10-60 years
Brief Summary
The rapid changes of tissue-typing technology, including the widely used of highly specific molecular typing methods and solid phase analysis technology for detection of alleles specific anti-HLA anti...
Detailed Description
This study is a retrospective cohort study. The investigators design to analyze the HLA high-resolution typing data of kidney transplant recipients from 2014 to the end of 2017 with HLA Matchmaker for...
Eligibility Criteria
Inclusion
- Patients with normal or nearly normal renal function after transplantation
- Patients with abnormal renal function indicators after transplantation but in a stable state without loss of function (serum creatinine 176-265 mmol/l)
- Patients who are able to take immunosuppressive agents orally in strict accordance with the doctor's instructions and can be regularly reviewed
Exclusion
- All patients with renal transplantation function damage caused by surgical factors, medicinal factors, acute tubular necrosis (ATN) and other factors
- Postoperative patients complicated with malignant tumors or infectious diseases such as tuberculosis and hepatitis
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03818698
Start Date
April 1 2019
End Date
December 31 2022
Last Update
May 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China, 710061